New approaches to treatment of secondary hyperparathyroidism
Locatelli, F.; Limardo, M.; Pontoriero, G.
Current Opinion in Investigational Drugs 9(4): 363-370
2008
ISSN/ISBN: 1472-4472 PMID: 18393103 Document Number: 616073
A large number of patients with chronic kidney disease are affected by secondary hyperparathyroidism. The related mineral metabolism abnormalities are associated with an increased relative risk of morbidity and mortality. The management of secondary hyperparathyroidism is made more complex by the fact that the disease progresses over time. Recent approaches to its management include vitamin D analogs, non-calcium/non-aluminum containing phosphate binders and calcimimetics.